Halo main article

Article

Register to be able to access the wonderful content on this site. Your FREE registration entitles you to a, b, c and helps earn a donation to Doctors without Borders.

Register to be able to access the wonderful content on this site. Your FREE registration entitles you to a, b, c and helps earn a donation to Doctors without Borders.

Curabitur ac sagittis odio. Duis ipsum est, elementum non cursus ullamcorper, euismod quis tellus. Donec tempor dignissim elit vitae tempor. Etiam quis mi eros, sagittis faucibus turpis. Aenean aliquam, ligula eget tristique consectetur, enim turpis consequat eros, fringilla placerat massa diam sit amet erat. Sed pellentesque iaculis metus, sed interdum ipsum malesuada non. Etiam ac massa felis, id lobortis elit. Maecenas sapien felis, aliquet eu vulputate a, tristique vehicula augue. Quisque egestas, nisl sit amet suscipit semper, nisi metus cursus eros, ac pretium diam massa mattis diam.

Ut et nisl libero, non interdum augue. Nunc rutrum odio ac erat condimentum molestie non vel augue. Duis tempus, odio at aliquet pulvinar, sem magna porta mauris, vel interdum massa urna vel massa. Aenean sit amet sodales tellus. Proin in est sit amet sem accumsan commodo. Nullam suscipit ipsum non nisi rutrum ut commodo enim gravida. Phasellus non elit sit amet tellus posuere ullamcorper. Cras metus velit, porta ut eleifend id, interdum hendrerit tortor.

 

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content